Acura Pharmaceuticals (OTCMKTS:ACUR) Shares Pass Above 200-Day Moving Average – Time to Sell?

Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR – Get Free Report) passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.0001. Acura Pharmaceuticals shares last traded at $0.00, with a volume of 0 shares changing hands.

Acura Pharmaceuticals Stock Performance

About Acura Pharmaceuticals

(Get Free Report)

Acura Pharmaceuticals Inc is a specialty pharmaceutical company focused on developing and commercializing products designed to deter prescription drug abuse and misuse. The company’s core business centers on proprietary drug formulations that incorporate its Aversion and ARCUS® abuse-deterrent technologies. These platforms are intended to make it more difficult to tamper with or extract active pharmaceutical ingredients from oral dosage forms, helping to address public health concerns around opioid and stimulant abuse.

Acura’s lead product, Oxaydo®, is an immediate‐release oxycodone tablet that employs Aversion® technology to discourage tampering and intravenous abuse.

Recommended Stories

• Five stocks we like better than Acura Pharmaceuticals
• Copper’s Record Rally Highlights a Deeper Supply Problem
• Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
• Optical Cable Corporation Is Starting to Get the Market’s Attention
• Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers